Drug Use-Results Survey for SYMPROIC Tablets 0.2mg in cancer patients with opioid-induced constipatio

Not Applicable

• Conditions: Opioid-induced constipation

• Registration Number: JPRN-UMIN000042851
• Lead Sponsor: Shionogi & Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-06-30
• Study Start: 2020-12-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 1202

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence rates of adverse drug reactions

Secondary Outcome Measures

Name	Time	Method
Improvement rates of frequency and condition of bowel movement (2 weeks later, 4 weeks later, 8 weeks later,12 weeks later or at discontinuation)